Learning Objectives: 

Dr. Amit Grewal

1. Briefly review the concept of Polygenic Risk Scores and their potential utility for augmenting clinical management of common chronic medical conditions.

2. Review data collected from the "Clinical Implementation of Polygenic Risk Scores for Cardio-Renal-Metabolic Disease: Uptake and Impact in a Large Community Health System"  research study. 

3. Highlight the potential impact that Polygenic Risk Scores may have in the future with respect to personalized medicine. 

Dr. Keon Karimabady

1. Identify patients with MASLD in the primary care setting by applying current diagnostic criteria and validated risk stratification tools.

2. Implement practical workflow strategies into routine primary care practice to assess and address lifestyle risk factors. 

Dr. Mohammad Salah

1. Recognize the role of right ventricular dysfunction in risk stratification  and management of acute pulmonary embolism.

2. Describe the clinical utility of AI-assisted echocardiographic interpretation in the assessment of right ventricular function.

3. Identify the potential advantages and limitation of artificial intelligence as an adjunct to standard echocardiographic interpretation in acute care settings.

Dr. Osama Siddiqui

1. Describe the differences between monogenic and polygenic contributors to cardiovascular risk.

2. Discuss the current state of genetic risk assessment in the prevention of coronary artery disease.

3. Explore the potential clinical applications of integrated monogenic and polygenic risk stratification.